Nalbuphine coadministered with morphine prevents tolerance and dependence

Anesthesia and Analgesia

Volumn 84, Issue 4, 1997, Pages 810-815

  Lee, Shih Chun ^a   Wang, Jhi Joung ^a,b   Ho, Shung Tai ^a   Tao, Pao Luh ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b CATHAY GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; NALBUPHINE; NALOXONE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG DEPENDENCE; DRUG EFFECT; DRUG TOLERANCE; DRUG WITHDRAWAL; MALE; NAUSEA; NONHUMAN; PRIORITY JOURNAL; PRURITUS; RAT; RESPIRATION DEPRESSION; VOMITING;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESICS, OPIOID; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; DRUG TOLERANCE; MALE; MORPHINE; NALBUPHINE; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030976753     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199704000-00021     Document Type: Article

References (28)

1. Schmidt WK, Tam SW, Shotzberger GS, et al. Nalbuphine. Drug Alcohol Depend 1985;14:339-62.
2. 3 analgesic in mice. J Pharmcol Exp Ther 1992;262:1044-50.
3. De Souza EB, Schmidt WK, Kuhar MJ. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic. J Pharmacol Exp Ther 1988;244:391-401.
4. Walker EA, Young AM. Discriminative-stimulus effects of the low efficacy μ agonist nalbuphine. J Pharmacol Exp Ther 1993;267:322-30.
5. Chen JC, Smith ER, Cahill M, et al. The opioid receptor binding of dezocine, morphine, fentanyl, butorphanol and nalbuphine. Life Sci 1992;52:389-96.
6. Bailey PL, Clark NJ, Pace NL, et al. Antagonism of postoperative opioid-induced respiratory depression: nalbuphine versus naloxone. Anesth Analg 1987;66:1109-14.
7. Davies GG, From R. A blinded study using nalbuphine for prevention of pruritus induced by epidural fentanyl. Anesthesiology 1988;69:763-5.
8. Penning JP, Samson B, Baxter AD. Reversal of epidural morphine-induced respiratory depression and pruritus with nalbuphine. Can J Anaesth 1988;35:599-604.
9. Baxter AD, Samson B, Penning J, et al. Prevention of epidural morphine-induced respiratory depression with intravenous nalbuphine infusion in post-thoracotomy patients. Can J Anaesth 1989;36:503-9.
10. Mills CA, Flacke JW, Flacke WE, et al. Narcotic reversal in hypercapnic dogs: comparison of naloxone and nalbuphine. Can J Anaesth 1990;37:238-44.
11. Cohen SE, Ratner EF, Kreitzman TR, et al. Nalbuphine is better than naloxone for treatment of side effects after epidural morphine. Anesth Analg 1992;75:747-52.
12. Mushlin BE, Cochin J. Tolerance to morphine in the rat: its prevention by naloxone. Life Sci 1976;18:797-802.
13. Yano I, Takemori AE. Inhibition by naloxone of tolerance and dependence in mice treated acutely and chronically with morphine. Res Commun Chem Pathol Pharmacol 1977;16:721-34.
14. Kayser V, Guibaud G. The analgesic effects of morphine, but not those of the enkephalinase inhibitor thiorphan, are enhanced in arthritic rats. Brain Res 1983;267:131-8.
15. Brennum J, Kjeldsen M, Jensen K, Jensen TS. Measurements of human pressure-pain thresholds of fingers and toes. Pain 1989;38:211-7.
16. Chung SC, Kim JH, Kim HS. Reliability and validity of the pressure pain thresholds (PPT) in the TMJ capsules by electronic algometer. J Craniomandib Pract 1993;11:171-6.
17. Kayser V, Besson JM, Guilbaud G. Effects of the analgesic agent tramadol in normal and arthritic rats: comparison with the effects of different opioids, including tolerance and cross-tolerance to morphine. Eur J Pharmacol 1991;195:37-45.
18. Wei E, Loh HH, Way EL. Quantitative aspects of precipitated abstinence in morphine-dependence rats. J Pharmacol Exp Ther 1973;184:389-403.
19. Etches RC, Sandler AN, Lawson SL. A comparison of the analgesic and respiratory effects of epidural nalbuphine or morphine in postthoracotomy patients. Anesthesiology 1991;75:9-14.
20. Pugh GC, Drummond GB. A dose-response study with nalbuphine hydrochloride for pain in patients after upper abdominal surgery. Br J Anaesth 1987;59:1356-63.
21. Yamamoto T, Ohno M, Ueki S. A selective κ-opioid agonist, U-50,488H, blocks the development of tolerance to morphine analgesia in rats. Eur J Pharmacol 1988;156:173-6.
22. Tao PL, Hwang CL, Chen CY. U-50,488 blocks the development of morphine tolerance and dependence at a very low dose in guinea pigs. Eur J Pharmacol 1994;256:281-6.
23. Takemori AE, Loh HH, Lee NM. Suppression by dynorphin A-(1-13) of the expression of opiate withdrawal and tolerance in mice. Eur J Pharmacol 1992;221:223-6.
24. Green PG, Lee NM. Dynorphin-A-((1-13) attenuates withdrawal in morphine-dependent rats: effect of route of administration. Eur J Pharmacol 1988;145:267-72.
25. DeLander GE, Portoghese PS, Takemori AE. Role of spinal μ opioid receptors in the development of morphine tolerance and dependence. J Pharmacol Exp Ther 1984;231:91-6.
26. Yu VC, Sadée W. Efficacy and tolerance of narcotic analgesics at the μ opioid receptor in differentiated human neuroblastoma cells. J Pharmacol Exp Ther 1988;245:350-5.
27. Adams RE, Wooten GF. Is morphine dependence mediated exclusively by the μ receptor? Neurochem Res 1993;18:1041-5.
28. Loomis CW, Penning J, Milne B. A study of the analgesic interaction between intrathecal morphine and subcutaneous nalbuphine in the rat. Anesthesiology 1989;71:704-10.